Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | PLSE |
---|---|---|
09:32 ET | 2278 | 20.57 |
09:38 ET | 850 | 20.41 |
09:39 ET | 200 | 20.495 |
09:45 ET | 1287 | 20.565 |
09:48 ET | 621 | 20.3928 |
09:54 ET | 207 | 20.56 |
09:59 ET | 1500 | 20.58 |
10:03 ET | 450 | 20.353 |
10:08 ET | 100 | 20.35 |
10:10 ET | 200 | 20.49 |
10:12 ET | 200 | 20.37 |
10:14 ET | 100 | 20.525 |
10:15 ET | 355 | 20.461 |
10:17 ET | 2415 | 20.5999 |
10:19 ET | 100 | 20.44 |
10:26 ET | 410 | 20.63 |
10:32 ET | 2246 | 20.645 |
10:35 ET | 100 | 20.495 |
10:42 ET | 111 | 20.3939 |
10:46 ET | 400 | 20.52 |
10:50 ET | 100 | 20.58 |
10:51 ET | 100 | 20.63 |
10:55 ET | 705 | 20.46 |
11:02 ET | 1076 | 20.208 |
11:06 ET | 100 | 20.285 |
11:08 ET | 100 | 20.285 |
11:11 ET | 300 | 20.45 |
11:13 ET | 6821 | 20.61 |
11:15 ET | 100 | 20.65 |
11:18 ET | 200 | 20.72 |
11:20 ET | 200 | 20.91 |
11:22 ET | 100 | 20.8 |
11:24 ET | 100 | 20.91 |
11:27 ET | 100 | 20.91 |
11:29 ET | 100 | 20.96 |
11:31 ET | 12933 | 20.9584 |
11:33 ET | 100 | 21.03 |
11:38 ET | 350 | 20.93 |
11:42 ET | 100 | 21.02 |
11:44 ET | 100 | 21.02 |
11:45 ET | 400 | 20.77 |
11:47 ET | 300 | 20.7 |
12:00 ET | 100 | 20.89 |
12:02 ET | 700 | 20.7 |
12:09 ET | 200 | 20.5 |
12:12 ET | 100 | 20.78 |
12:14 ET | 100 | 20.87 |
12:18 ET | 450 | 20.87 |
12:21 ET | 100 | 20.87 |
12:23 ET | 300 | 20.835 |
12:25 ET | 20687 | 20.56 |
12:27 ET | 100 | 20.56 |
12:30 ET | 300 | 20.56 |
12:32 ET | 293 | 20.72 |
12:34 ET | 302 | 20.76 |
12:38 ET | 244 | 20.92 |
12:41 ET | 1460 | 20.8 |
12:43 ET | 100 | 20.54 |
12:45 ET | 100 | 20.81 |
12:50 ET | 100 | 20.47 |
12:52 ET | 500 | 20.5347 |
12:54 ET | 975 | 20.53 |
12:57 ET | 100 | 20.52 |
12:59 ET | 200 | 20.4 |
01:01 ET | 214 | 20.51 |
01:03 ET | 300 | 20.535 |
01:14 ET | 300 | 20.38 |
01:24 ET | 369 | 20.48 |
01:32 ET | 100 | 20.59 |
01:33 ET | 300 | 20.42 |
01:35 ET | 400 | 20.38 |
01:39 ET | 200 | 20.4146 |
01:44 ET | 100 | 20.37 |
01:55 ET | 200 | 20.45 |
01:57 ET | 200 | 20.33 |
02:00 ET | 100 | 20.47 |
02:04 ET | 2971 | 20.5 |
02:08 ET | 200 | 20.45 |
02:09 ET | 100 | 20.41 |
02:11 ET | 303 | 20.4 |
02:22 ET | 300 | 20.25 |
02:29 ET | 600 | 20.44 |
02:33 ET | 223 | 20.39 |
02:38 ET | 200 | 20.43 |
02:42 ET | 200 | 20.44 |
02:45 ET | 200 | 20.415 |
02:47 ET | 200 | 20.45 |
02:49 ET | 200 | 20.31 |
03:02 ET | 200 | 20.44 |
03:03 ET | 2500 | 20.365 |
03:05 ET | 100 | 20.42 |
03:07 ET | 436 | 20.29 |
03:09 ET | 100 | 20.41 |
03:14 ET | 100 | 20.42 |
03:16 ET | 100 | 20.48 |
03:20 ET | 100 | 20.49 |
03:21 ET | 100 | 20.41 |
03:23 ET | 500 | 20.41 |
03:25 ET | 249 | 20.3 |
03:27 ET | 517 | 20.287 |
03:38 ET | 443 | 20.36 |
03:39 ET | 1085 | 20.39 |
03:41 ET | 864 | 20.445 |
03:43 ET | 1102 | 20.42 |
03:45 ET | 12100 | 20.3 |
03:48 ET | 600 | 20.3 |
03:50 ET | 100 | 20.255 |
03:52 ET | 300 | 20.28 |
03:54 ET | 1000 | 20.52 |
03:56 ET | 4276 | 20.3324 |
03:57 ET | 4492 | 20.22 |
03:59 ET | 28484 | 20.33 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Pulse Biosciences Inc | 1.2B | -25.7x | --- |
Nano-X Imaging Ltd | 366.2M | -6.4x | --- |
Atlantic International Corp | 301.1M | -0.7x | --- |
Simulations Plus Inc | 641.2M | 67.3x | +3.18% |
IRadimed Corp | 621.6M | 33.2x | +21.02% |
Clearpoint Neuro Inc | 342.2M | -16.9x | --- |
Pulse Biosciences, Inc. is a bioelectric medicine company. The Company’s proprietary CellFX nsPFA technology delivers nanosecond pulses of electrical energy to non-thermally clear cells while sparing adjacent noncellular tissue. The Company is engaged in the development of its CellFX nsPFA technology for use in the treatment of atrial fibrillation and in a select few other markets where it could have a profound positive impact on healthcare for both patients and providers. The Company’s Nano-pulse Stimulation (NPS) technology is an energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. The Company has designed a variety of applicators, or end-effectors, to explore the potential use of the CellFX platform to treat disorders in other medical specialties, such as cardiology, gastroenterology, gynecology, and ear, nose, and throat.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.2B |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 61.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.74 |
EPS | $-0.79 |
Book Value | $0.80 |
P/E Ratio | -25.7x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.